POTI', Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.750
AS - Asia 3.024
EU - Europa 2.058
SA - Sud America 447
AF - Africa 186
Continente sconosciuto - Info sul continente non disponibili 113
OC - Oceania 2
Totale 9.580
Nazione #
US - Stati Uniti d'America 3.660
SG - Singapore 1.153
CN - Cina 794
IT - Italia 526
VN - Vietnam 396
BR - Brasile 346
IE - Irlanda 319
HK - Hong Kong 251
SE - Svezia 245
FI - Finlandia 210
DE - Germania 192
BD - Bangladesh 149
ZA - Sudafrica 143
UA - Ucraina 126
FR - Francia 99
NL - Olanda 94
TR - Turchia 82
RU - Federazione Russa 70
CA - Canada 50
GB - Regno Unito 50
AR - Argentina 47
AT - Austria 44
IN - India 32
ID - Indonesia 20
IQ - Iraq 19
JP - Giappone 19
MX - Messico 19
KR - Corea 18
BE - Belgio 16
CZ - Repubblica Ceca 13
PL - Polonia 13
CL - Cile 12
EC - Ecuador 10
PK - Pakistan 10
CI - Costa d'Avorio 9
CO - Colombia 9
ES - Italia 9
SA - Arabia Saudita 9
JO - Giordania 8
MY - Malesia 8
PH - Filippine 8
UZ - Uzbekistan 8
EU - Europa 7
TN - Tunisia 7
VE - Venezuela 7
JM - Giamaica 6
PY - Paraguay 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
IR - Iran 5
MA - Marocco 5
RO - Romania 5
AL - Albania 4
BG - Bulgaria 4
LT - Lituania 4
TH - Thailandia 4
UY - Uruguay 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
HN - Honduras 2
HR - Croazia 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
Totale 9.465
Città #
Singapore 590
Ashburn 393
San Jose 362
Chandler 349
Dublin 319
Santa Clara 300
Hong Kong 233
Beijing 208
Dallas 206
Ann Arbor 145
Jacksonville 142
Council Bluffs 139
Johannesburg 129
Ho Chi Minh City 122
Parma 112
Dearborn 108
New York 108
Boardman 103
Hanoi 95
Houston 87
Princeton 73
Izmir 68
Nanjing 65
Lauterbourg 62
Los Angeles 57
Chicago 56
Wilmington 52
Hefei 47
Shanghai 45
Vienna 36
Columbus 35
Helsinki 33
Moscow 32
San Mateo 31
Toronto 31
Munich 30
Milan 29
São Paulo 29
Buffalo 28
Bremen 27
Nanchang 24
Des Moines 23
Seattle 23
Haiphong 22
Bologna 20
Hebei 20
Jinan 20
Rho 20
Shenyang 20
The Dalles 18
Brussels 16
Frankfurt am Main 16
Tokyo 16
Jakarta 15
Jiaxing 15
Brooklyn 14
Changsha 14
Da Nang 14
Fremont 14
Guangzhou 14
Tianjin 14
Belo Horizonte 13
Orem 13
Rome 13
Seoul 12
Kunming 11
Modena 11
Brno 10
Fairfield 10
Naples 10
Rio de Janeiro 10
Turku 10
Abidjan 9
Denver 9
San Francisco 9
Warsaw 9
Washington 9
Zhengzhou 9
Biên Hòa 8
Manchester 8
Montreal 8
Nuremberg 8
Stockholm 8
Amman 7
Atlanta 7
Chengdu 7
Grafing 7
Hangzhou 7
London 7
Phoenix 7
Redondo Beach 7
Tashkent 7
Turin 7
Baghdad 6
Bergamo 6
Charlotte 6
Hillsboro 6
Hải Dương 6
Marseille 6
Riyadh 6
Totale 5.817
Nome #
Treatments for COVID-19: emerging drugs against the coronavirus 255
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 252
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 241
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 218
Effects of the radiocontrast agent iodixanol on endothelial cell morphology and function. 201
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 187
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 181
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 169
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 166
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 165
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 165
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 156
Drug-drug interactions in polypharmacy patients: The impact of renal impairment 153
EFFETTI DEI MEZZI DI CONTRASTO E DELLA N-ACETILCISTEINA SU MORFOLOGIA E FUNZIONE DELLE CELLULE ENDOTELIALI UMANE 152
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 148
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 147
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 146
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 145
Critical and emerging topics in dietary carbohydrates and health 145
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 144
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 143
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies 143
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 142
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 138
Identification of sclerostin as a putative new myokine involved in the muscle-to-bone crosstalk 136
'Spare' Luteinizing Hormone Receptors: Facts and Fiction 135
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 135
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 132
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 128
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 123
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 121
Aortic Gene Expression Profiles Show How ApoA-I Levels Modulate Inflammation, Lysosomal Activity, and Sphingolipid Metabolism in Murine Atherosclerosis 119
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 118
IN VIVO TREATMENT WITH CYCLOSPORINE A INCREASES EFFLUX POTENTIAL OF MOUSE PLASMA VIA ATP-BINDING CASSETTE TRANSPORTER ABCA1 117
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 117
Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) 114
Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions 114
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 114
ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN VIVO 112
Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis 112
Gnrh antagonists produce differential modulation of the signaling pathways mediated by gnrh receptors 110
Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein 110
Impact of apolipoprotein E (apoE) deficiency on reverse cholesterol transport in vivo 109
Sphingosine-1 phosphate induces cAMP/PKA-independent phosphorylation of the cAMP response element-binding protein (CREB) in granulosa cells 107
Effect of LXR agonists on reverse cholesterol transport in vivo 102
Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways 101
Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP 101
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro 100
Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice 99
Glycosylation pattern and in vitro bioactivity of reference follitropin alfa and biosimilars 96
The liver-X-receptor agonist T0901317 stimulates in vivo reverse cholesterol transport in mice 95
Meccanismo di attivazione dell’ATP-binding cassette A1 da parte del cAMP 94
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 94
Pharmacogenetics of GPCR variants: FSH receptor and infertility treatment 92
COVID-19 … What are drugs and strategies now? 91
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice 91
Effect of the LXR agonist T0901317 on reverse cholesterol transport in vivo 90
Editorial: Pharmacology of endocrine related GPCRs 88
EFFECTS OF RADIOLOGY CONTRAST MEDIA ON CULTURED HUMAN ENDOTHELIAL CELL MORPHOLOGY AND FUNCTION AND PROTECTIVE ACTION OF N-ACETYLCYSTEIN AND ROSUVASTATIN 88
The in vivo stimulation of LXR promotes the reverse cholesterol transport in vivo by increasing the efflux potential of sera 87
La rosuvastatina promuove il trasporto inverso del colesterolo nei topi 87
SKI-II - a sphingosine kinase 1 inhibitor - exacerbates atherosclerosisin low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet 85
Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity 85
Il cAMP attiva l’ATP-Binding Cassette A1 (ABCA1) attraverso un duplice meccanismo 84
The LXR agonist T0901317 increases the efflux potential of sera and promotes the reverse cholesterol transport in mice 82
In vivo stimulation of LXR increases the efflux potential of sera and promotes the reverse cholesterol transport 81
Sphingosine 1-phosphate receptor 1 signaling in macrophages reduces atherosclerosis in LDL receptor–deficient mice 79
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression 79
Seizures of illicit substances for personal use in two Italian provinces: Analysis of trends by type and purity from 2008 to 2017 79
WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis 78
Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro 78
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R-/-) mice 77
Sphingolipids and atherosclerosis: focus on Sphingosine 1-Phosphate (S1P) 77
Sphingosine 1-Phosphate (S1P): a bridge between HDL, inflammation and atherosclerosis? 75
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/-mice 73
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R -/-) mice 70
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 64
Molecular basis of androgen action on human sexual desire 63
Osteocytes specific GSK3 inhibition affects in vitro osteogenic differentiation 60
The “hitchhiker’s guide to the galaxy” of endothelial dysfunction markers in human fertility 60
Treatments for COVID-19: Emerging drugs against the coronavirus-reply 55
Desorption electrospray ionization mass spectrometry imaging (DESI-MSI) for the detection of flavan-3-ol metabolites in mimetic model tissues 15
Totale 9.580
Categoria #
all - tutte 35.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022378 0 15 16 9 25 18 65 54 20 27 6 123
2022/20231.260 140 100 79 114 131 147 13 89 380 14 41 12
2023/2024557 23 42 13 21 26 140 31 54 19 34 45 109
2024/20251.732 46 88 115 126 185 210 49 63 231 152 134 333
2025/20263.790 356 396 443 273 578 147 397 162 407 248 264 119
2026/2027224 84 140 0 0 0 0 0 0 0 0 0 0
Totale 9.580